Hiranmoy Das

Hiranmoy Das is an American biomedical scientist and educator. He is currently a Professor in the Department of Pharmaceutical Sciences at the Texas Tech University Health Sciences Center (TTUHSC) Jerry H. Hodge School of Pharmacy, where he directs the Vascular Biology and Stem Cell Research Laboratory. He is a Fellow of the American Heart Association (FAHA), the Royal Society of Biology (FRSB), and the National Academy of Inventors (FNAI).

Early life and education Das was born in Tripura, India. He studied at the University of Calcutta, where he earned a Bachelor of Science (Honours) in zoology in 1984, a Master of Science in zoology in 1987, and a PhD in biochemistry in 1995.

Career Das began his career as a scientific officer at the Chittaranjan National Cancer Institute in Kolkata, India, where he worked from 1991 to 1996.

He later joined Harvard Medical School as an instructor in medicine, holding appointments in both the Division of Rheumatology, Immunology and Allergy and the Division of Cardiovascular Medicine at Brigham and Women's Hospital.

In 2006, he was appointed assistant professor of internal medicine at Case Western Reserve University. He subsequently moved to Ohio State University, where he served as associate professor of internal medicine and director of cardiovascular stem cell research laboratories from 2008 to 2016.

Research Das's research is primarily focused on vascular biology, stem cell biology, and regenerative medicine. His work examines the molecular and cellular mechanisms underlying inflammation, tissue repair, and disease progression.

A central area of his research involves the role of transcription factors, particularly Krüppel-like factor 2 (KLF2), in regulating processes such as autophagy, mitophagy, mitochondrial function, and reactive oxygen species signaling. His studies have investigated how these pathways influence cellular homeostasis and contribute to conditions including atherosclerosis, rheumatoid arthritis, and cardiovascular disease.

Das has also conducted research on the therapeutic potential of stem cells, including hematopoietic stem cells and dental pulp stem cells, in tissue repair and regeneration. His work explores applications in bone regeneration, wound healing, neurodegenerative disorders, and inflammatory diseases.

In addition, his research has addressed mechanisms of osteoclast and osteoblast activity in bone remodeling, as well as the role of stem cells in neuroinflammation and cancer-related processes.

Das has led and participated in research projects supported by the National Institutes of Health (NIH), including studies on stem cell–based therapies, corneal diseases, and immune-mediated conditions, often focusing on the regulatory role of KLF2 in disease pathways.

Honors and awards 2008–2013 – National Institutes of Health / NIAMS K01 Career Development Award 2021 – Fellow of the American Heart Association (FAHA) 2021–2022 – Chancellor's Council Distinguished Research Award, Texas Tech University Health Sciences Center 2022 – President's Excellence in Research Award, Texas Tech University Health Sciences Center 2024 – Fellow of the National Academy of Inventors 2026 – Fellow of the Royal Society of Biology

Books Das, Hiranmoy (ed.) (2018). Bone Regeneration: Concepts, Clinical Aspects and Future Directions. Nova Science Publishers. Das, Hiranmoy (ed.) (2020). Methods in Molecular Biology: Wound Regeneration. Humana Press. Das, Hiranmoy (ed.) (2025). Tissue Repair and Regeneration: Elucidating Cellular and Molecular Mechanisms with Therapeutic Implications. Springer Nature.

Selected publications